Simplex Trading’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Simplex Trading’s Portfolio ZNTL Stock Details ZNTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.08K	Buy	+2,600	New	+$6.71K	﹤0.01%	7752
2025 Q4	–	Sell	-16,000	Closed	-$24K	–	10325
2025 Q3	$24K	Hold	16,000	–	–	﹤0.01%	7199
2025 Q2	$18K	Buy	16,000 +10,200	+176%	+$13.5K	﹤0.01%	6878
2025 Q1	$9K	Buy	5,800 +4,000	+222%	+$8.63K	﹤0.01%	7210
2024 Q4	$5K	Sell	1,800 -20,500	-92%	-$67.2K	﹤0.01%	7681
2024 Q3	$82K	Buy	22,300 +21,900	+5,475%	+$79.6K	﹤0.01%	5420
2024 Q2	$1K	Buy	+400	New	+$4.47K	﹤0.01%	8596
2023 Q4	–	Sell	-5,400	Closed	-$108K	–	10010
2023 Q3	$108K	Buy	5,400 +4,100	+315%	+$104K	﹤0.01%	5008
2023 Q2	$36K	Buy	+1,300	New	+$31.2K	﹤0.01%	6164

Other funds holding ZNTL

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $273M AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Simplex Trading's ZNTL Position: Q1 2026 in Review

Simplex Trading opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q1 2026: 98,554 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #4135 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ZNTL as recently as Q2 2025.

Simplex Trading first reported a position in ZNTL in Q3 2023 and has held it in 7 quarters since. The position peaked at $470K in Q4 2023. 102 funds tracked by Wall St. Rank hold ZNTL as of Q1 2026.

Simplex Trading held 98,554 shares of Zentalis Pharmaceuticals worth $231K as of Q1 2026.
Zentalis Pharmaceuticals was a new Simplex Trading position in Q1 2026.
Zentalis Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4135 holding.
Simplex Trading first reported a position in Zentalis Pharmaceuticals in Q3 2023 and has held it in 7 quarters since.
Simplex Trading's Zentalis Pharmaceuticals position peaked at $470K in Q4 2023.
102 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.